SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,313,241,000 | +5.1% | 13,465 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,249,417,000 | +29.8% | 13,465 | -3.8% | 0.01% | +25.0% |
| Q3 2014 | $962,782,000 | -34.4% | 13,998 | -0.1% | 0.00% | -33.3% |
| Q2 2014 | $1,468,039,000 | +35.3% | 14,008 | +7.1% | 0.01% | +20.0% |
| Q1 2014 | $1,084,999,000 | +31.4% | 13,077 | +2.5% | 0.01% | +25.0% |
| Q4 2013 | $826,022,000 | +13.8% | 12,763 | +11.3% | 0.00% | 0.0% |
| Q3 2013 | $725,787,000 | +122.5% | 11,464 | +47.6% | 0.00% | +100.0% |
| Q2 2013 | $326,130,000 | – | 7,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |